Dr. Francisco Tellechea Rotta, MD

Dr. Rotta practices at Intercoastal Medical Group Inc in Sarasota, Florida.

Dr. Rotta's NPI, 1508418153, was assigned on July 14, 2019. Dr. Rotta graduated from Federal University of Rio Grande do Sul School of Medicine in 1992. Dr. Rotta holds Florida license ME139605.

Dr. Rotta's primary practice is Intercoastal Medical Group Inc, at 943 S Beneva Rd, Sarasota, FL 34232 in Sarasota County. The practice phone is (941) 955-1108.

Dr. Rotta's primary practice is Intercoastal Medical Group Inc in Sarasota, Florida. Dr. Rotta is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Legacy Healthcare Services. Dmand AI also links Dr. Rotta to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rotta practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Rotta's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Rotta is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Rotta's licenses on file in 2 states: Florida and Michigan.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, dementia, epilepsy, essential tremor and fibromyalgia and chronic pain among the conditions Dr. Rotta treats.

CMS data shows 20,029 Medicare services from Dr. Rotta across 26 procedure codes in 2024, for 1,160 Medicare patients. Medicare paid $317,356 for them.

CMS counts 1,160 Medicare patients who saw Dr. Rotta in 2024. The largest group is 75 to 84, with 500 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rotta's median patient age at 74, with 51% women.

In 2024, Dr. Rotta wrote 2,864 Medicare Part D claims for 677 patients. 94% of them were for generic drugs. CMS names the drug for 2,519 of them, across 50 drugs with 11 or more claims each, at $1,146,012 in total drug cost. In 2023, CMS named 2,370 claims across 46 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Rotta for performance year 2024, reported individually. Dr. Rotta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rotta as offering telehealth. CMS counts 30 procedures of skin biopsy by Dr. Rotta, more than 65% of the clinicians it reports for that procedure.

Dmand AI links 20 papers to Dr. Rotta, published from 2011 to 2023. 2020 was the busiest year, with 2. The most frequent topics are Brazil, Amyotrophic Lateral Sclerosis and Electromyography. Dr. Rotta has published most often in Arq Neuropsiquiatr. Dr. Rotta's most frequent co-authors are Walter G. Bradley, Jose G. Romano and Khema R. Sharma.

CMS Open Payments shows 270 general payments to Dr. Rotta from 46 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 89% of the total. Abbvie Inc. paid the most, $887. It also lists 1 research payment totaling $3,359 in 2021.

Dr. Rotta graduated from Federal University of Rio Grande do Sul School of Medicine in 1992.

Dr. Rotta is in network with 15 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.